Clinical utility of circulating tumor-associated cells to predict and monitor chemo-response in solid tumors.

To our knowledge, this is the first expansive and in-depth study demonstrating that real-time CRP of C-TACs is a viable approach for non-invasive assessment of response to CCA in solid organ cancers.